🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

“When we approach a healthy donor, it can take up to three months or longer from start to finish — but in this case, if we have a donor match identified in the inventory, the product can practically be shipped to us the next day. For patients with leukemias and other aggressive

2,850 days. Almost 8 years. That's how long it took to save a life. In August of 2016 my First Round partner, Bill Trenchard, led Ossium Health's Seed round. And in May of 2024, a 68 year-old woman in Michigan became the first patient to receive a bone marrow transplant from a

On this World Marrow Donor Day, we’re expressing our sincere gratitude to both living and deceased bone marrow donors and their families, who selflessly give to others to save lives. #WMDD24 #WMDD #thankyoudonor

We’re delighted to share that our next-generation viable bone matrix allograft, OssiGraft Prime™, has won the prestigious Spine Technology Award from Orthopedics This Week. This award recognizes groundbreaking advancements in spine surgery products. businesswire.com/news/home/2024…

We’re proud to partner with BARDA to advance our bone marrow product for radiological and nuclear emergencies. Our rapid-deployable cryopreserved bone marrow could help save lives in mass casualty events. Learn more about how we’re strengthening national preparedness:

We’re happy to see Click on Detroit share the story of a Michigan woman with leukemia who became the first to receive a successful bone marrow transplant from a deceased donor using our technology! This could offer new hope for blood cancer patients. 🙌 Full story:

Today’s edition of Forbes' emerging science and technology newsletter, The Prototype, covers how Ossium is “extending a lifeline to leukemia patients” by providing a new source of bone marrow for stem cell transplants.

San Francisco–based Ossium Health has carried out three transplants for cancer patients using stem cells from deceased donors’ bone marrow in recent months. wired.trib.al/dYRu3Of

Check out the WIRED coverage of the recent transplants with Ossium’s organ donor bone marrow, an informative piece by Emily Mullin on the need for new stem cell donor options and the enormous potential for Ossium’s technology to fill critical gaps and save lives.

After we reported the first transplant with Ossium’s organ donor bone marrow, several news outlets published stories on this milestone and what it means for the future of stem cell accessibility. We’ve compiled them here: ossiumhealth.com/ossium-in-the-…

We’re down in San Diego for some sunshine and the ASH Annual Meeting! Come visit us at booth 217 to hear more about how our organ donor bone marrow is already improving the availability, quality, and reliability of stem cell transplants for blood cancer patients

In this article from First Round, our CEO & Co-Founder Kevin Caldwell shares insight on how he reflects on past successes and failures to guide his decision-making. review.firstround.com/25-hard-questi…

We’re in Honolulu this week to exhibit at #Tandem2025! Join us at Booth 629 as we share exciting updates on how our bone marrow banking platform has already provided new options for stem cell transplant recipients through our PRESERVE I study and expanded access program. Read

Great feature in The Scientist on how Ossium’s bone marrow banking platform is transforming stem cell transplantation and expanding access for patients in need! Read more: the-scientist.com/bone-marrow-ba…

Our CEO Kevin Caldwell recently joined Ira S. Pastor on the Progress, Potential, And Possibilities podcast to discuss how Ossium is advancing stem cell science to improve patient outcomes and build a healthier future. Listen to the conversation here: youtube.com/watch?v=nZZB6B…

Happy National Donate Life Blue & Green Day! #BlueGreenDay #OssiumHealth

We’ll be out at Vitalist Bay in just a couple days! If you’ll be there, make sure to catch Kevin Caldwell’s talk on how Ossium’s current work in blood cancers paves the way for stem cell transplants in much broader applications, including eventually as a proactive immune system

Tomorrow at Vitalist Bay (April 4 - May 29) Ossium CEO Kevin Caldwell is speaking on how Ossium's work in treating acute malignancies is paving the way to an expansion into preventative longevity medicine. Catch the talk at 2:10pm on the main stage.

From transplant to healthspan, Ossium is banking on bone marrow... #longevity #bonemarrow #VitalistBay #OssiumHealth #immunity #regenerativemedicine Ossium Health Kevin Caldwell Vitalist Bay (April 4 - May 29) longevity.technology/news/from-tran…